{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to function as a mitochondrial Ser/Thr protein kinase and protect SN dopaminergic neurons against various cellular stresses. Autosomal recessive inheritance mode indicates that PARK6 mutation - induced loss of PINK1 function is involved in the pathogenesis of PARK6.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that PARK6 is caused by PINK1 mutations leading to loss of its function as a mitochondrial Ser/Thr protein kinase, which is relevant to the functional assay for the variant.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial membrane potential, mitochondrial morphology, and ROS formation, as well as MTT assay for neuronal death were used. These assays are used to investigate the role of PINK1 in maintaining mitochondrial function and the effect of PARK6 mutations.",
          "judgment": "Yes",
          "reasoning": "The assays effectively model the disease pathogenesis as they directly measure mitochondrial functions which are disrupted in PARK6 due to PINK1 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "All results are expressed as the mean ± SE value of n experiments. However, the paper does not explicitly state if both normal/negative/wild type AND abnormal/positive/null controls were used nor does it mention multiple replicates for each specific assay.",
          "judgment": "No",
          "reasoning": "Lack of clear information on the use of both types of controls and replicates for each assay.",
          "next_step_or_outcome": "Proceed to Sub - step 3b"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The assays like confocal imaging of mitochondrial membrane potential using TMRM, Mitotracker Green for mitochondrial morphology, MitoSOX Red and CM - H2DCFDA for ROS, and MTT assay for neuronal death are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "The assays used are broadly accepted historically in the field of mitochondrial and neuronal research.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "Based on the ACMG flowchart, the disease mechanism was clearly defined, the assays were applicable. But due to lack of information on basic controls and replicates, and as the assays are broadly accepted in the field, the functional evidence strength is PS3_supporting for the PINK1 G309D variant."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": "417"
        },
        "variant_string_id": "PINK1 E417G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to function as a mitochondrial Ser/Thr protein kinase and protect SN dopaminergic neurons against various cellular stresses. Autosomal recessive inheritance mode indicates that PARK6 mutation - induced loss of PINK1 function is involved in the pathogenesis of PARK6.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states the role of PINK1 mutations in PARK6 pathogenesis related to its function as a mitochondrial kinase.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial membrane potential, mitochondrial morphology, and ROS formation, as well as MTT assay for neuronal death were used. These assays are used to investigate the role of PINK1 in maintaining mitochondrial function and the effect of PARK6 mutations.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant to the disease mechanism as they study mitochondrial functions affected by PINK1 mutations in PARK6.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "All results are expressed as the mean ± SE value of n experiments. But the paper does not clearly mention the use of both normal/negative/wild type AND abnormal/positive/null controls and multiple replicates for each assay.",
          "judgment": "No",
          "reasoning": "Insufficient information on controls and replicates for each assay.",
          "next_step_or_outcome": "Proceed to Sub - step 3b"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The assays like confocal imaging of mitochondrial membrane potential using TMRM, Mitotracker Green for mitochondrial morphology, MitoSOX Red and CM - H2DCFDA for ROS, and MTT assay for neuronal death are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "These are well - established techniques in mitochondrial and neuronal research.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "As per the ACMG flowchart, the disease mechanism was defined, assays were applicable. Lack of information on basic controls and replicates, but with the assays being standard in the field, the functional evidence strength for PINK1 E417G is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "C - terminal sequence",
          "alt": "C - terminal deletion of 145 amino acids",
          "position": "C - terminal Δ145"
        },
        "variant_string_id": "PINK1 CΔ145"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to function as a mitochondrial Ser/Thr protein kinase and protect SN dopaminergic neurons against various cellular stresses. Autosomal recessive inheritance mode indicates that PARK6 mutation - induced loss of PINK1 function is involved in the pathogenesis of PARK6.",
          "judgment": "Yes",
          "reasoning": "The paper clearly links PINK1 mutations to PARK6 pathogenesis through loss of its mitochondrial kinase function.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial membrane potential, mitochondrial morphology, and ROS formation, as well as MTT assay for neuronal death were used. These assays are used to investigate the role of PINK1 in maintaining mitochondrial function and the effect of PARK6 mutations.",
          "judgment": "Yes",
          "reasoning": "The assays are related to the disease mechanism by examining mitochondrial functions affected by PINK1 mutations in PARK6.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "All results are expressed as the mean ± SE value of n experiments. However, details about the use of both normal/negative/wild type AND abnormal/positive/null controls and multiple replicates for each assay are not clearly provided.",
          "judgment": "No",
          "reasoning": "Inadequate information regarding controls and replicates for each assay.",
          "next_step_or_outcome": "Proceed to Sub - step 3b"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
          "extracted_paper_info": "The assays like confocal imaging of mitochondrial membrane potential using TMRM, Mitotracker Green for mitochondrial morphology, MitoSOX Red and CM - H2DCFDA for ROS, and MTT assay for neuronal death are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "These are commonly used and accepted techniques in the relevant research area.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "Following the ACMG flowchart, the disease mechanism was well - defined, assays were applicable. Due to lack of information on basic controls and replicates, and the assays being widely accepted, the functional evidence strength for PINK1 CΔ145 is PS3_supporting."
    }
  ]
}